https://vegfr-receptor.com/ind....ex.php/a-clear-case-
High relapse rate of intense myeloid leukemia (AML) continues to be a crucial issue despite considerable advances in anti-cancer therapies. One crucial reason for relapse is the existence of leukemia stem cells (LSCs) with self-renewal ability, which play a role in repeated therapy weight and recurrence. Treatments focusing on LSCs, particularly in combo with present chemotherapy regimens or hematopoietic stem cellular transplantation may help attain a greater total rem
Like
Comment
Share
